Puma Biotechnology, INC.
SEC CIK 1401667 · PBYI · last insider filing 2026-06-15
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Moyes JAY M | Director | filed 2012 - 2026 |
| Miller Michael Patrick | Director | filed 2018 - 2026 |
| Wilson Troy Edward | Director | filed 2013 - 2026 |
| Senderowicz Adrian | Director | filed 2015 - 2026 |
| Dorval Allison | Director | filed 2021 - 2026 |
| Stuglik Brian M | Director | filed 2020 - 2026 |
| Cesano Alessandra | Director | filed 2022 - 2026 |
| Auerbach Alan H | Director · President and CEO | filed 2011 - 2026 |
| Miller Ann Calby | Director | filed 2019 - 2021 |
| Zavrl Frank | Director | filed 2015 - 2020 |
| O'Dowd Hugh | Director | filed 2019 - 2020 |
| Malley Thomas | Director | filed 2011 - 2014 |
| Johnson Robert Andrew | Director · President | filed 2007 - 2011 |
| Munjal Kapil | Director | filed 2007 - 2011 |
| Siddiqi Faraaz | Director · Secretary | filed 2007 - 2011 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Hunt Douglas M | See Remarks | filed 2018 - 2026 |
| Nougues Maximo F | Chief Financial Officer | filed 2018 - 2026 |
| Ludwig Jeffrey Jerome | Chief Commercial Officer | filed 2020 - 2025 |
| Wong Alvin F | Chief Scientific Officer | filed 2021 - 2024 |
| Bryce Richard Paul | SR VP, CLINICAL RESEARCH & DEV | filed 2012 - 2021 |
| Lo Steven | Chief Commercial Officer | filed 2015 - 2019 |
| Eyler Charles R | SR. VP-FINANCE & TREASURER | filed 2011 - 2019 |
| Charnas Robert | See Remarks | filed 2016 - 2017 |
| Phillips Richard Benton | Sr VP Reg Affairs & QA | filed 2011 - 2016 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.